Michael Cox, Pharm.D., M.H.Sc., BCOP

Circle Pharma, Senior Vice President, Head of Early Development

Dr. Michael Cox currently serves as Senior Vice President, Head of Early Development at Circle Pharma. Over his career, he has led the clinical development, product launches, and life cycle management of numerous oncology products for pediatric and adult patients including tovorafenib (ojemdaTM), selpercatinib (Retvmo®), larotrectinib (VITRAKVI®), radium-223 (Xofigo®), regorafenib (Stivarga®), sorafenib (Nexavar®), cetuximab (ERBITUX®), denosumab (XGEVA®), and darbepoetin alfa (Aranesp®).

Prior to joining Circle, Dr. Cox served as Vice President, Clinical Development at Day One Biopharmaceuticals where he led the pediatric clinical development program for tovorafenib. Prior to Day One, he held global and regional clinical development and medical affairs positions of increasing responsibility at Loxo Oncology (aquired by Eli. Lilly & Co), South San Francsico, California; Bayer Consumer Care AG, Basel, Switzerland; Merck KGaA, Darmstadt, Germany; and Amgen, Inc., Thousand Oaks, California.

Dr. Cox has published abstracts and manuscripts in journals including The New England Journal of Medicine, Lancet Oncology, the Journal of Clinical Oncology, Cancer, and Clinical Cancer Research. He is a member of numerous cancer research organizations including the American Association of Cancer Research, the American Society of Clinical Oncology, and the European Society of Medical Oncology.

Dr. Cox received his Pharm.D. from Ohio Northern University and an M.H.Sc. in Clinical Research from Duke University’s School of Medicine. Dr. Cox completed pharmacy practice residencies at Mission Hospitals in Asheville, North Carolina and the University of Pittsburgh Cancer Institute – University of Pittsburgh Medical Cancer in Pittsburgh, Pennsylvania. He completed a medical oncology/clinical drug development fellowship in the Clinical Pharmacology Section, Center for Cancer Research at the National Cancer Institute in Bethesda, Maryland. Dr. Cox is a Board-Certified Oncology Pharmacist.